Lv3
294 积分 2024-10-14 加入
A promising future in cancer immunotherapy: Oncolytic viruses
2天前
已完结
Oncolytic virus preclinical toxicology studies
2天前
已完结
Antibody drug conjugate adverse effects can be understood and addressed based on immune complex clearance mechanisms
2天前
已完结
Antibody drug conjugate adverse effects can be understood and addressed based on immune complex clearance mechanisms
2天前
已关闭
Assessing the interplay between off-target promiscuity, cytotoxicity, and tolerability in rodents to improve the safety profile of novel anti-malarial plasmepsin X inhibitors
4天前
求助中
In vitroimmunogenicity prediction: bridging between innate and adaptive immunity
5天前
已完结
How Biologics Have Changed the Drug Discovery Landscape
5天前
已完结
Rethinking the Necessity of Long-term Toxicity Studies for Biotherapeutics Using Weight of Evidence Assessment
5天前
已完结
Do longer duration nonclinical toxicology studies provide predictive clinical safety value? The IQ consortium longer duration nonclinical to clinical translational database
5天前
已完结
Challenges and opportunities for the future of monoclonal antibody development: Improving safety assessment and reducing animal use
5天前
已关闭
皖公网安备34019202002308
